institute of virology (viro)

Font size »A . A+ . A++ .

Publications 2004

 

 

  • Bruss V: Processing of hepatitis B virus surface proteins. Methods Mol Med. 2004, 95: 189-198.
  • Bruss V: Envelopment of the hepatitis B virus nucleocapsid. Virus Res. 2004, 106: 199-209.
  • Cosma A, Bühler S, Nagaraj R, Staib C, Hammarin AL, Wahren B, Goebel FD, Erfle V, Sutter G: Neutralization assay using a Modified Vaccinia Virus Ankara Vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against Vaccinia Virus. Clin Diagn Lab Immunol. 2004, 11/2: 406-410.
  • Drexler I, Staib C, Sutter G: Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential? Curr Opin Biotechnol. 2004, 15: 506-512.
  • Fleischer K, Schmidt B, Kastenmüller W, Busch DH, Drexler I, Sutter G, Heike M, Peschel C, Bernhard H: Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro. J Immunol. 2004, 172: 162-169.
  • Greenwood AD, Engelbrecht CC, MacPhee RD: Characterization of an endogenous retrovirus class in elephants and their relatives. BMC Evol Biol. 2004, 4: 38.
  • Herrmann F, Lehr H, Drexler I, Sutter G, Hengstler J, Wollscheid U, Seliger B: HER-2/neu-Mediated Regulation of Components of the MHC Class I Antigen-Processing Pathway. Cancer Res. 2004, 64: 215-220.
  • Hultström AL, Bratt G, Cosma A, Erfle V, Wahren, B, Carbone E: Autologous cytotoxicity of natural killer cells derived from HIV-infected patients. Immunol Lett. 2004, 91/2-3: 155-8.
  • Koopman G, Mortier D, Hofman S, Niphuis H, Fagrouch Z, Norley S, Sutter G, Liljeström P, Heeny JI: Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens. J Gen Virol. 2004, 85: 2915-2924.
  • Kramer-Hämmerle S, Rothenaigner I, Brack-Werner R: Differenzierung einer humanen neuralen Stammzelllinie unter verschiedenen Wachstumsbedingungen Biospektrum 2004, 6/10: 796- 98
  • Leib-Mösch C, Seifarth W, Schön U: Influence of human endogenous retroviruses on cellular gene expression. Buchbeitrag in E. Sverdlov: Retroviruses and Primate Genome Evolution, Eurekah: Chapter 7:1-22, 2004.
  • Lotz C, Antunes Ferreira E, Drexler I, Abdel Mutallib S, Huber C, Sutter G, Theobald M: Partial tyrosinase-specific self tolerance by HLA-A*0201-restricted cytotoxic T lymphocytes in mice and man. Int J Cancer. 2004, 108: 571-579.
  • Mäkitalo B, Lundholm P, Hinkula J, Nilsson C, Karlén K, Mörner A, Sutter G, Erfle V, Heeny JL, Wahren B, Biberfeld G, Thorstensson R: Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen. J Gen Virol. 2004, 85: 2407-2419.
  • Matzen K, Dirkx A, oude Egbrink M, Speth C, Götte M, Ascherl G, Grimm T, Griffioen A, Stürzl M: HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associates vasculopathy Virus Res. 2004, 104: 145-155.
  • Naschberger E, Werner T, Vicente AB, Guenzi E, Töpolt K, Leubert R, Lubeseder-Martellato C, Nelson PJ, Stürzl M: Nuclear factor-ЌB motif and interferon-α-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem J. 2004, 379: 409-420.
  • Olszewska W, Suezer Y, Sutter G, Openshaw PJM: Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins. Vaccine 2004, 23: 215-221.
  • Rafalska I, Zhang Z, Benderska N, Wolff H, Hartmann AM, Brack-Werner R, Stamm S: The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation. Hum Mol Genet. 2004, 13: 1535-1549.
  • Staib C, Drexler I, Sutter G: Construction and isolation of recombinant MVA. Methods Mol Biol. 2004, 269: 77-100.
  • Sprinzl M, Dumortier J, Protzer U: Construction of recombinant adenoviruses that produce infectious hepattis B virus. Methods Mol Med. 2004, 96: 203-218.
  • Untergasser A, Protzer U: Hepatitis B virus vectors allow elimination of viral gene expression and insertion of foreign promoters. Humn Gene Ther. 2004, 15: 203-210.
  • Zhang Z, Protzer U, Hu Z, Jacob J, Liang TJ: Inhibition of cellular proteasome activities enhances hepadnaviral replication in a HBx dependent manner. J Virol. 2004, 78: 4566-4572.